Tuesday, September 12, 2017 -- An MRI scan of a brain from a person with multiple sclerosis.
Wednesday, September 13, 2017 -- A new clinical trial will explore three interventions in improving one of the most disabling symptoms for people with multiple sclerosis: fatigue. The Patient-Centered Outcomes Research Institute has approved a $3,476,448 funding award over four years to Michigan Medicine’s Tiffany Braley, M.D., M.S. and Anna Kratz, Ph.D.
Wednesday, October 25, 2017 -- (Natural News) A recent study published in the Journal of Neuroinflammation revealed a mechanism that may one day help identify the root cause of multiple sclerosis, and develop long-overdue treatments for the disease. As part of the study, a team of international researchers from the University of Exeter in the U.K. and the University of Alberta in Canada examined brain... Read More
Monday, July 03, 2017 -- Researchers reveal that lipoic acid - an over-the-counter antioxidant - helped to reduce whole brain atrophy in patients with secondary progressive MS.
Wednesday, August 09, 2017 -- Multiple sclerosis, a debilitating autoimmune disease, is difficult to treat. New research looking at the role of gut bacteria offers new hope.
Friday, November 03, 2017 -- Looking for possible causes of multiple sclerosis, researchers found that people who had a concussion prior to age 20 had a greater risk of developing MS, suggesting head injuries are a risk factor. The post Researchers may have discovered a cause of multiple sclerosis appeared first on Harvard Health Blog.
Friday, September 22, 2017 -- Using a new gene immunotherapy technique, researchers have reversed clinical symptoms of multiple sclerosis in mice, including paralysis.
Tuesday, August 01, 2017 -- Resistance training twice per week for 6 months may reduce brain atrophy in patients with relapsing-remitting multiple sclerosis, new study reveals.
Friday, December 08, 2017 -- Those who ate the healthiest diet consumed an average of 1.7 servings of whole grains per day.
Wednesday, October 04, 2017 -- (Reuters) - Mylan NV said the U.S. Food and Drug Administration has approved two doses of its generic version of Teva's Copaxone used to treat patients with relapsing forms of multiple sclerosis.
Thursday, July 20, 2017 -- (Natural News) The results of a new pilot study showed the efficacy of lipoic acid in the reduction of whole brain atrophy among patients with secondary progressive multiple sclerosis (SPMS) compared with recently approved FDA drug ocrelizumab (brand name Ocrevus). In a randomized, double-blind study, researchers found that a daily dose of 1,200 mg of... Read More
Wednesday, July 19, 2017 -- (Natural News) Breastfeeding is believed to have a plethora of benefits for both mother and child, and American researchers have uncovered another one. According to the team from Oakland, California-based health care company Kaiser Permanente, breastfeeding for at least 15 months may actually protect women against multiple sclerosis (MS), a chronic, progressive disease that affects... Read More
Wednesday, September 20, 2017 -- Two related cytokines may signal which individuals will progress to the severe form of MS more rapidly. The finding could aid drug research.
Thursday, September 14, 2017 -- A large-scale study suggests that vitamin D levels may predict MS risk in young and middle-aged women. Correcting this deficiency may lower that risk.
Friday, October 06, 2017 -- Public health campaigns to raise awareness of the risks of vitamin D deficiency may help reduce the incidence of MS.
Thursday, November 23, 2017 -- A new study in a mouse model of MS reveals two ways in which Th1 and Th17 immune cells cross the blood-barrier to attack the central nervous system.
Monday, August 21, 2017 -- Discoveries and breakthroughs in multiple sclerosis research are building momentum, but just how close are we to finding a cure? We investigate.
Sunday, July 30, 2017 -- What is the Swank diet, and how might it help treat multiple sclerosis? We look at the origin of the Swank diet, how it works, and the benefits and risks.
Friday, October 20, 2017 -- A new study investigates if physical exercise improves functional capacity and quality of life for those diagnosed with multiple sclerosis. What is Multiple Sclerosis? Multiple sclerosis (MS) is an autoimmune disease which causes damage to the central nervous system by eating away at myelin, the fatty layer that covers nerve cells to insulate them and […] The post Does Exercise Improve Quality of Life for Those with Multiple Sclerosis? appeared first on Medical News Bulletin.
Friday, November 10, 2017 -- Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod.